Capital Expenditures - Getinge AB (STO:GETI B) - Alpha Spread

Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 227.2 SEK 1.52% Market Closed
Market Cap: 61.9B SEK
Have any thoughts about
Getinge AB?
Write Note

Getinge AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Getinge AB
Capital Expenditures Peer Comparison

Comparables:
EKTA B
S
SUS
CEVI
ARJO B
ELOS B

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Getinge AB
STO:GETI B
Capital Expenditures
-kr1.4B
CAGR 3-Years
-9%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Capital Expenditures
-kr1.6B
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Capital Expenditures
-kr50.7m
CAGR 3-Years
-78%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Capital Expenditures
-kr78.2m
CAGR 3-Years
-23%
CAGR 5-Years
-32%
CAGR 10-Years
-17%
Arjo AB (publ)
STO:ARJO B
Capital Expenditures
-kr403m
CAGR 3-Years
21%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Elos Medtech AB
STO:ELOS B
Capital Expenditures
-kr117.2m
CAGR 3-Years
-6%
CAGR 5-Years
-26%
CAGR 10-Years
N/A

See Also

What is Getinge AB's Capital Expenditures?
Capital Expenditures
-1.4B SEK

Based on the financial report for Dec 31, 2023, Getinge AB's Capital Expenditures amounts to -1.4B SEK.

What is Getinge AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
0%

Over the last year, the Capital Expenditures growth was -19%. The average annual Capital Expenditures growth rates for Getinge AB have been -9% over the past three years .

Back to Top